Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Radiation. Found 14 abstracts

Dong Y, Ridge JA, Ebersole B, Li T, Lango MN, Churilla TM, Donocoff K, Bauman JR, Galloway TJ. Incidence and outcomes of radiation-induced late cranial neuropathy in 10-year survivors of head and neck cancer. Oral Oncol. 2019 Aug;95:59-64.
Kim AH, Konety B, Chen Z, Schumacher F, Kutikov A, Smaldone M, Abouassaly R, Khanna A, Kim SP. Comparative Effectiveness of Local and Systemic Therapy for T4 Prostate Cancer. Urology. 2018 Oct;120:173-9.
Roberts ME, Aynardi JT, Chu CS. Uterine leiomyosarcoma: A review of the literature and update on management options. Gynecol Oncol. 2018 Dec;151(3):562-72.   PMCID: Review
Chera B, Wang K, Monroe A, Galloway T, Amdur R, Hayes DN, Zevallos J, Mendenhall WM. Truth or myth: Definitive chemoradiotherapy doesn't work for HPV/p16 negative oropharyngeal squamous cell carcinoma?. Oral Oncol. 2017 Feb;65:125-6.
Dong Y, Li T, Churilla TM, Shaikh T, Sigurdson ER, Bleicher RJ, Weiss SE, Hayes SB, Anderson PR. Impact of rheumatoid arthritis on radiation-related toxicity and cosmesis in breast cancer patients: a contemporary matched-pair analysis. Breast Cancer Res Treat. 2017 Dec;166(3):787-91.
Dong Y, Ridge JA, Li T, Lango MN, Churilla TM, Bauman JR, Galloway TJ. Long-term toxicities in 10-year survivors of radiation treatment for head and neck cancer. Oral Oncol. 2017 Aug;71:122-8.
Johnson SB, Soulos PR, Shafman TD, Mantz CA, Dosoretz AP, Ross R, Finkelstein SE, Collins SP, Suy S, Brower JV, Ritter MA, King CR, Kupelian PA, Horwitz EM, Pollack A, Abramowitz MC, Hallman MA, Faria S, Gross CP, Yu JB. Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer. Radiother Oncol. 2016 Nov;121(2):294-8.
Porpiglia AS, Reddy SS, Farma JM. Retroperitoneal Sarcomas. Surg Clin North Am. 2016 Oct;96(5):993-1001.
Murphy CT, Devarajan K, Wang LS, Mehra R, Ridge JA, Fundakowski C, Galloway TJ. Pre-treatment tumor-specific growth rate as a temporal biomarker that predicts treatment failure and improves risk stratification for oropharyngeal cancer. Oral Oncol. 2015 Nov;51(11):1034-40.
Singla S, Papavasiliou P, Powers B, Gaughan J, von Mehren M, Watson JC, Farma JM. Challenges in the treatment of angiosarcoma: a single institution experience. Am J Surg. 2014 Aug;208(2):254-9.
Pahlajani N, Ruth KJ, Buyyounouski MK, Chen DY, Horwitz EM, Hanks GE, Price RA, Pollack A. RADIOTHERAPY DOSES OF 80 GY AND HIGHER ARE ASSOCIATED WITH LOWER MORTALITY IN MEN WITH GLEASON SCORE 8 TO 10 PROSTATE CANCER. International Journal of Radiation Oncology Biology Physics. 2012 Apr;82(5):1949-56.   PMCID: PMC3827957
Park CC, Yom SS, Podgorsak MB, Harris E, Price RA, Bevan A, Pouliot J, Konski AA, Wallner PE, Elect Brachytherapy Working Grp. AMERICAN SOCIETY FOR THERAPEUTIC RADIOLOGY AND ONCOLOGY (ASTRO) EMERGING TECHNOLOGY COMMITTEE REPORT ON ELECTRONIC BRACHYTHERAPY. International Journal of Radiation Oncology Biology Physics. 2010 Mar;76(4):963-72.   PMCID: not NIH funded
Thames HD, Kuban D, Levy LB, Horwitz EM, Kupelian P, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A. The role of overall treatment time in the outcome of radiotherapy of prostate cancer: An analysis of biochemical failure in 4839 men treated between 1987 and 1995. Radiotherapy and Oncology. 2010 Jul;96(1):6-12.   PMCID: Not required
Lawton CA, Michalski J, El-Naqa I, Buyyounouski MK, Lee WR, Menard C, O'Meara E, Rosenthal SA, Ritter M, Seider M. RTOG GU RADIATION ONCOLOGY SPECIALISTS REACH CONSENSUS ON PELVIC LYMPH NODE VOLUMES FOR HIGH-RISK PROSTATE CANCER. International Journal of Radiation Oncology Biology Physics. 2009 Jun;74(2):383-7.   PMCID: PMC2905150
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Radiation

Radiation Prostate cancer Chemotherapy Hnc Chemoradiation Surgery Hpv Hypofractionated radiation-therapy intraoperative radiotherapy iort Breast Neoplasms Aged IRRADIATION 10-Year survivorship device drug therapy THERAPY duration distant metastases Angiosarcoma Dose escalation mortality local-control Cosmesis defining biochemical failure Cranial nerve palsy androgen randomized controlled-trial Leiomyosarcoma Prostatectomy irradiation Young Adult IMRT Hemangiosarcoma Survivorship High grade terminology alpha DEPRIVATION Time factor T4 Oropharynx cancer Combined Modality Therapy Long-term follow-up p16 Electronic Brachytherapy hypofractionation RADICAL Radiotherapy conformal radiation-therapy Head and Neck Neoplasms Male clinically localized adenocarcinoma escalation trial Chemothearpy Head and neck cancer Long-term toxicity Breast cancer Female Target volume rates Rheumatoid arthritis Quality of life Sbrt Prognosis NEOADJUVANT Survival intensity-modulated radiotherapy Kaplan-Meier Estimate TRIAL beta ratio oncology Prostate-specific antigen carcinoma EXTERNAL-BEAM RADIOTHERAPY stage breast-cancer tumor-control LYMPHADENECTOMY Morcellation oncology guidelines radiotherapy CLINICAL TARGET VOLUME phase-iii trial boost diagnosis energy x-rays competing risk protraction Adult PROSTATECTOMY Systemic therapy interoperative ANDROGEN SUPPRESSION suppression Targeted therapy fractionation Toxicity Middle Aged Pelvic lymph nodes Retroperitoneal sarcoma Oropharynx 80 and over Aged Uterine sarcoma Growth rate Retroperitoneal liposarcoma
Last updated on Friday, December 06, 2019